Mereo Biopharma Group Plc ADR (MREO) saw an uptrend of 1.11% in the recent trading with $4.56 being its most recent. The current price level -9.16% lower than the highest price of $5.02 marked by the stock while trading over the past 52-weeks, whereas it is 196.10% higher than the lowest price of $1.54 the company dropped to over past 52-weeks. The latest news story on MREO appeared in (Insider Monkey) under the title “Is Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
Squeezing the time span to 30 day period shows us the stock is currently trading -1.72% below one month high and is +15.74% above of the lowest during that time.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 2 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.20 for the stock.
Mereo Biopharma Group Plc ADR Earnings – What Happened With MREO
Coming around sales and income figures on MREO Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
MREO – Mereo Biopharma Group Plc ADR Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 153.76 million. MREO does have institutional investors; and they hold 57.63% of the stock.
Mereo Biopharma Group Plc ADR – Insider Activity and Holdings
As on 2024-06-30, RUBRIC CAPITAL MANAGEMENT LP was the top most holder in Mereo Biopharma Group Plc ADR (NASDAQ:MREO) with an ownership of 15.31 million shares of the company or 2.1859 of the stake worth $55.11 million. The filing also reveals ADAGE CAPITAL PARTNERS GP, L.L.C. as the second largest holder in the company with a control over 1.6838 of the outstanding shares. Its stake is worth $42.45 million for having 11.79 million shares in hand.
ROCK SPRINGS CAPITAL MANAGEMENT LP also came holding a key position in the company during the recent quarter and it now holds 1.3257 of the outstanding shares. With this there are now 87.0 institutions which have possession in MREO’s shares.
Currently, the stock has been recommended as Strong Buy by 2 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.20 for the stock.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Mereo Biopharma Group Plc ADR has a debt to equity ratio of 0.08.
